FDA Inspection 1325110 — Dr. Michael Montana, M.D.
The FDA completed an inspection of Dr. Michael Montana, M.D. on Jun 18, 2026 in St. Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- St. Louis, MO (United States)
Additional Details
Clinical BA/BE